Höfs Lennart, Geißler-Lösch David, Falkenburger Björn H
Department of Neurology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.
Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), 01307 Dresden, Germany.
Cells. 2025 Aug 29;14(17):1340. doi: 10.3390/cells14171340.
The aggregation of α-synuclein (αSyn) is a central feature of Parkinson's disease (PD) and other synucleinopathies. The efficient clearance of αSyn depends largely on the autophagy-lysosomal pathway. Emerging genetic evidence highlights the role of pleckstrin homology and RUN domain-containing M1 protein (PLEKHM1), a critical regulator of autophagosome-lysosome fusion, in the pathogenesis of multiple neurodegenerative diseases. This study investigates the possible effects of increased PLEKHM1 expression on αSyn pathology and neurodegeneration in mice. We utilized a mouse model of PD that is based on A53T-αSyn overexpression, achieved by the stereotactic injection of recombinant adeno-associated viral vectors (rAAV) into the substantia nigra. Additionally, this study explores the effect of PLEKHM1 overexpression on the autophagy-lysosomal pathway under physiological conditions, using transgenic autophagy reporter mice. PLEKHM1 overexpression facilitated the αSyn-induced degeneration of dopaminergic somata in the substantia nigra and degeneration of dopaminergic axon terminals in the striatum. In concert with αSyn expression, PLEKHM1 also potentiated microglial activation. The extent of αSyn pathology, as reported by staining for phosphorylated αSyn, was not affected by PLEKHM1. Using RFP-EGFP-LC3 autophagy reporter mice, rAAV-mediated PLEKHM1 overexpression reduced lysosomal and autolysosomal area, increased LAMP1-LC3 colocalization, and decreased the autolysosome-to-autophagosome ratio. Concurrently, PLEKHM1 overexpression in both genotypes caused p62 accumulation, accompanied by reduced overlap with lysosomal and autophagosomal markers but increased colocalization with autolysosomal markers, indicating impaired cargo degradation during late-stage autophagy. Taken together, elevated PLEKHM1 levels exacerbate neurodegeneration in αSyn-overexpressing mice, possibly by impairing autophagic flux. Now, with in vivo evidence complementing genetic data, alterations in PLEKHM1 expression appear to compromise autophagy, potentially enhancing neuronal vulnerability to secondary insults like αSyn pathology.
α-突触核蛋白(αSyn)的聚集是帕金森病(PD)和其他突触核蛋白病的核心特征。αSyn的有效清除很大程度上依赖于自噬-溶酶体途径。新出现的遗传学证据突出了含pleckstrin同源结构域和RUN结构域的M1蛋白(PLEKHM1),一种自噬体-溶酶体融合的关键调节因子,在多种神经退行性疾病发病机制中的作用。本研究调查了PLEKHM1表达增加对小鼠αSyn病理和神经退行性变的可能影响。我们利用了一种基于A53T-αSyn过表达的PD小鼠模型,通过将重组腺相关病毒载体(rAAV)立体定向注射到黑质中来实现。此外,本研究使用转基因自噬报告小鼠,探索了生理条件下PLEKHM1过表达对自噬-溶酶体途径的影响。PLEKHM1过表达促进了αSyn诱导的黑质中多巴胺能神经元胞体的变性以及纹状体中多巴胺能轴突终末的变性。与αSyn表达协同,PLEKHM1还增强了小胶质细胞的激活。通过磷酸化αSyn染色报告的αSyn病理程度不受PLEKHM1影响。使用RFP-EGFP-LC3自噬报告小鼠,rAAV介导的PLEKHM1过表达减少了溶酶体和自噬溶酶体面积,增加了LAMP1-LC3共定位,并降低了自噬溶酶体与自噬体的比例。同时,两种基因型中PLEKHM1过表达均导致p62积累,伴随着与溶酶体和自噬体标记物重叠减少但与自噬溶酶体标记物共定位增加,表明晚期自噬过程中货物降解受损。综上所述,升高的PLEKHM1水平可能通过损害自噬流加剧αSyn过表达小鼠的神经退行性变。现在,有了体内证据补充遗传数据,PLEKHM1表达的改变似乎会损害自噬,可能增强神经元对诸如αSyn病理等继发性损伤的易感性。